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Abstract: Achieving complete surgical cytoreduction in advanced stage high grade serous ovarian
cancer (HGSOC) patients warrants an availability of Critical Care Unit (CCU) beds. Machine Learning
(ML) could be helpful in monitoring CCU admissions to improve standards of care. We aimed to
improve the accuracy of predicting CCU admission in HGSOC patients by ML algorithms and
developed an ML-based predictive score. A cohort of 291 advanced stage HGSOC patients with
fully curated data was selected. Several linear and non-linear distances, and quadratic discriminant
ML methods, were employed to derive prediction information for CCU admission. When all the
variables were included in the model, the prediction accuracies were higher for linear discriminant
(0.90) and quadratic discriminant (0.93) methods compared with conventional logistic regression
(0.84). Feature selection identified pre-treatment albumin, surgical complexity score, estimated blood
loss, operative time, and bowel resection with stoma as the most significant prediction features.
The real-time prediction accuracy of the Graphical User Interface CCU calculator reached 95%.
Limited, potentially modifiable, mostly intra-operative factors contributing to CCU admission were
identified and suggest areas for targeted interventions. The accurate quantification of CCU admission
patterns is critical information when counseling patients about peri-operative risks related to their
cytoreductive surgery.
Keywords: Machine Learning; surgical cytoreduction; Critical Care Unit; ovarian cancer; Graphical
User Interface
1. Introduction
Cancer of the fallopian tube, ovary, or peritoneum (EOC) is the leading cause of death
from gynaecological malignancy in the western world [1]. Over 70% of women diagnosed
with EOC have advanced stage disease at presentation (International Federation Obstetrics
and Gynaecology FIGO stage 3–4) [1]. The gynaecological oncology community is now rec-
ognizing high grade serous ovarian cancer (HGSOC), as yet the most prevalent, as a single
clinical entity. For such an aggressive subtype, identification of novel, ideal biomarkers
that strongly correlates with the stage and may be effective for early diagnosis, remains
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critical [2]. The cornerstone of treatment includes a combination of surgical cytoreduction
and platinum-based chemotherapy aiming at elimination of all visible disease, ideally
reaching a total macroscopic tumor clearance. When the cancer is at an advanced stage, the
debulking surgery often requires prolonged surgical times and possible multi-visceral re-
sections, necessitating Critical Care Unit (CCU) support, and prolonged hospitalization [3].
Risk-prediction models of severe post-operative complications after ovarian cytoreductive
surgery have been thoroughly proposed [4].
Routine post-operative CCU admission has been considered a standard of care for such
patients at risk of increased peri-operative morbidity and mortality, and post-operative
complications [5]. Patient-related pre-operative risk factors associated with significant
peri-operative outcomes have been comprehensively studied [6]. There is currently a
growing interest in monitoring CCU admissions, and performance has been compared
across different trusts to improve the standards of care. In the realm of precision medicine,
innovative data mining technologies, such as Machine Learning (ML), can be clearly used
for monitoring quality improvement and effectiveness of delivery of modern ovarian cancer
care. The ML approach for outcome prediction based on fully curated clinical data has
been applied in a variety of hospital settings [7]. We previously developed ML algorithms
to improve the prediction accuracy of complete cytoreduction in advanced stage HGSOC
patients [8]. In addition, we highlighted the importance of feature selection for the ML-
based two-year prognosis estimation in the same population [9]. The usefulness of ML as a
prognostic toll in the ovarian cancer environment has been increasingly demonstrated [10].
Accurate prediction is difficult with conventional statistics, because patient character-
istics show a multidimensional and non-linear relationship. Machine Learning methods
could be helpful in monitoring CCU admissions to improve standards of care. In an era
of stringent economics, CCU admission is often arbitrary, driven by local practice or bed
availability. It remains heavily at the surgeon’s discretion, as post-operatively, the gynae-
cologic oncologist is mainly responsible for daily monitoring and decision making with
regards to the patient’s recovery [5]. International comparison studies have suggested that
patterns of CCU admission after surgery are inconsistent, and the value of such admissions
routinely may be nuanced [6]. While focusing on the cost-effectiveness of CCU utilization
after major surgeries, timely identification of those patients, who will benefit from CCU
support, remains a major challenge [11]. Lately, the introduction of maximal surgical effort
to achieve complete cytoreduction without compromising peri-operative management
and subsequent recovery requires the availability of CCU beds [12]. This paradigm shift
has prompted the development of tools to accurately predict CCU admission following
cytoreductive surgery. To inform consent and enhance decision making, we developed and
validated an ML-based risk score to predict CCU admission of advanced stage HGSOC pa-
tients undergoing surgical cytoredution. We hypothesized that CCU admission of HGSOC
patients is multifactorial and could be accurately predicted by using ML algorithms. The
primary outcome was the prediction accuracy of several ML prediction methods, based
on a set of performance metrics, and the performance comparison with the conventional
logistic regression (LR) analysis. The secondary objective was factor refinement for CCU ad-
mission and exploration of the associations between CCU admission, severe post-operative
complications, hospital stay, and 30-day hospital re-admission.
2. Materials and Methods
Prospectively registered data in the hospital-wide Patient Pathway Manager (PPM)
database from 291 consecutive HGSOC women, who underwent cytoreductive surgery at
St James’s University Hospital, Leeds by a certified Gynaecologic Oncology Surgeon from
January 2014 to December 2019 was analyzed. This database was developed internally for
clinical trials and integrated with an electronic patient record system [13]. Our hospital is
a tertiary centre, recently accredited by the European Society of Gynaecologic Oncology
(ESGO) as a centre of excellence for ovarian cancer surgery. The staging was reported by
the 2014 International Federation of Gynaecology and Obstetrics classification [14].
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Women underwent either primary debulking surgery (PDS) or 3–4 cycles of neoad-
juvant chemotherapy (NACT) followed by interval debulking surgery (IDS) if they had:
FIGO stage 4 disease; poor performance status (PS); uncertainty about the possibility of
optimal tumor removal. Only HGSOC patients with at least one pre-treatment CA125
measurement were included in the study. Patients aged < 18 years, as well as those with
progressive disease, synchronous primary malignancy or secondary cytoreduction, were
excluded. Post-operative CCU admission was considered for high-risk HGSOC patients,
who were scheduled to undergo complex major surgery, including multi-visceral resections
or undertook pre-operative cardiopulmonary exercise (CPEX) fitness testing, if they were
deemed high risk at pre-assessment [15].
2.1. Candidate Variables for Prediction Model
Candidate predictors were selected a priori from two domains:
• Patient: age, year of diagnosis, body mass index (BMI), pre-operative co-morbidities
(Charlson Co-morbidity Index (CCI)), Eastern Co-operative Oncology Group (ECOG)
performance status (PS), and pre-operative albumin.
• Operative factors: timing of surgery (PDS or IDS), operative time (OT), surgical
complexity score (SCS), bowel resection with stoma formation (yes/no), residual
disease (RD), and estimated blood loss (EBL).
All these variables are widely available at tertiary centres. Based on clinical experience,
they have been previously shown to be independent predictors of post-operative morbidity
and mortality for ovarian cancer patients [4]. Severe post-operative complications were
reported according to the Clavien-Dindo morbidity score (grade 3–5) [16]. Only several
surgical site infections (SSIs) were recorded. The CCI was categorized as: 0, 1, 2 with higher
scores indicating greater co-morbidity [17]. The SCS was assigned based on the Aletti
classification as low, intermediate, and high [18]. Outcomes also included rate of CCU
admission, length of hospital stays, and hospital re-admission, defined as admission to any
hospital for longer than 24 h within 30 days of discharge.
Descriptive statistics were displayed by frequency and percentages for binary and
categorical variables and by means and standard deviation s(SD) or medians (with lower
or upper quartiles for continuous variables). The Chi-square test was performed for
categorical variables. The Fischer’s exact tests were used for binary variables. All analyses
were performed with IBM® SPSS® 26.0 Statistics Software for Windows (IBM, New York,
NY, USA).
2.2. Feature Reduction and Selection
Our objective was to use all the available data to maximize the generalizability of our
results. Feature selection from the candidate predictors aimed to optimize the predictor
group by finding the smallest independent set of variables with the greatest association to
the outcome in question, in order to ensure best performance and to minimize over-fitting.
We used standard feature selection strategies, including dropping-O variance and highly
correlated variables. All clinical variables were evaluated individually, one by one, with
the vector of CCU classification responses. Forward selection and backward stepwise
regression were then employed to select independent variables for inclusion in the final
models. Variables with a threshold p-value < 0.05 and 95% Confidence Intervals (CI) were
considered to be statistically significant and were included in the predictive model. To
re-value two variables as more relevant, and to optimize the latent collinearity and avert
variable over-fitting, a correlation analysis was evaluated by assessing the determination
coefficient (R2) and the root mean square error of cross validation (RMSECV). A poor
correlation between variables was observed if the R2 was low or the RMSECV was elevated.
Variables with a threshold of >0.6 were eliminated to determine the final input variables for
the model. Highly inter-correlated variables were grouped, and variables with no mutual
optimization were dropped. The resulting rankings were used to select the set of features
that led to the highest prediction accuracy. Subsequently, the optimal number of important
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features resulting in the highest prediction accuracy was identified. For feature importance,
we employed resources for assigning weight to system variables. That is, for any chosen
ML method, we assigned different weights to different variables.
2.3. Model Development and Training
The model development followed a standard data science approach. The raw clinical
data were imported into MATLAB environment (MathWorks Inc, MA, USA) for pre-
processing and subsequent multivariate analysis. The data set was randomly split into
training and test cohorts (60:40% ratio) with repeated random sampling (bootstrap), until
there was no significant difference (p = 0.20) between the two cohorts with respect to all
variables. The training set was used for model construction. A specific type of cross-
validation was employed—the CV LOO, in which each sample from the training set was
evaluated using the model built by all the other samples in the same training set. This was
used to check and define important parameters. The remaining samples assigned to the
test set were used to evaluate the model performance. For the Artificial Neural Network
(ANN) models in the regression mode, all the data were used, and sample selection differed
by using the Kennard-Stine method with 60% for training and 40% for testing. Subjects
with missing values were omitted. Following the pre-processing stage, all the quantitative
variables were normalized. Categorical variables were transformed into binary dummy
variables. Next, different subsets of data were labeled to solve the classification prediction
problem, namely CCU admission, as positive or negative. This was then formulated as a
binary classification problem. For all methods and to avoid over-fitting or selection bias, a
leave-one-out cross-validation (VB-CV) was applied to test the model’s ability to predict
new data by computing a statistic on the left-out sample. Only subjects with fully curated
data were eligible for the prediction analysis.
2.4. Multivariate Analysis
Initially, the model was evaluated variable by variable in a univariate fashion, but
there was no trend observed. Various state-of-the-art supervised classifiers, suitable for
the type and size of the data set, were tested in a multivariate fashion. The algorithms
were chosen because of their relative simplicity for interpretation and overall popularity
within the data science community and through our own testing of several ML algorithms
during model development, focusing on different types of interactions [19]. Algorithms
included the non-linear distance models using neural networks (K-Nearest Neighbors
(KNN), ANN in Backpropagation Neural Network (BPN) mode, and the models using
linear and quadratic discriminant methods (LDA and QDA)). A popular ML model is the
ANN; roughly modeled around the way human brain works, it is useful for supervised
prediction tasks [20]. Its variation, the BPN, is a type of neural network training that fine-
tunes the weights of a neural network based on the error rate obtained from the previous
iteration. Proper tuning of the weights allows for reduction of error rates and makes
the model reliable, thus increasing its generalizability. This method helps to calculate
the gradient of a loss of function with respect to all the weights in the network. A basic
prediction technique, such as KNN is employed to verify the complexity of the prediction
problem. Linear logistic regression (LR) was used as a benchmark. The conceptually simple
approach of LDA and its sibling, QDA, remain among the most effective procedures in the
domain of high-dimensional prediction [21,22].
2.5. Model Performance
To fully evaluate the discriminatory effectiveness of the model, we calculated several
performance metrics including accuracy, sensitivity, specificity, F-scores, and the area under
the receiver operating characteristic curve (AUC) for the test set. The accuracy represents
the total number of samples correctly classified considering true and false negatives. We
examined the model performance including all the variables as well as the simplest model
with the highest and more robust performance (less features). The sensitivity represented
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the proportion of positive samples correctly classified. The specificity represented the
proportion of negative samples correctly classified and finally, the F-score measured the
model performance considering imbalanced data. A Receiver Operating Curve (ROC) was
generated as a single metric that is not dependent on the discrimination threshold.
2.6. Development of the CCU Risk Calculator
For clinical utility, and to generate real-time predictions, numerous CCU prediction
tests at different model probability output thresholds were performed in the validation set,
and checked in the derivation set. Because most of the data were classified into one group
or another with no intervals, we developed a similar method, using the ANN(BPN) model
in calibration mode to turn discrete values into continuous values. A total of five features
were selected as threshold, given their significance, and offering the best compromise
of computing time required and possible information loss. A certain range of values,
minimum and maximum were set for each feature, as below:
Surgical Complexity Score: 2–18;
Albumin levels: 17–49;
Estimated Blood Loss: 100–4000;
Operative Time: 65–445;
Bowel Resection: 0–1;
A software tool (Calibration Tools Hall, UFRN, Natal, Brazil, upon request) by using
the ANN(BPN) regression algorithm was developed based on five selected predictor
features. The algorithm is a method of fine-tuning the weights of a neural network based
on the error rate obtained in the preceding iteration. Proper weight tuning reduces the error
rates rendering the model reliable, and increasing its generalizability. Entering values above
or below made the Graphical User Interface reset to the closest minimum/maximum value
in one or all input variables. All values were numerically entered, and the ‘Estimate Risk’
button was pressed to obtain the estimate in three different formats that complemented
each other as a result. The combination of these five features would yield 30 multivariate
sets of predictors to evaluate in three different modeling thresholds. These thresholds were
influenced by the data distribution and clinical importance of various cut-offs; the entire
data set, merging both training and test sets, was then used to report the CCU admission
probability percentages. The development of the predictive models and the report of
the findings were used in accordance with the EQUATOR Guideline for reporting ML
predictive models [23], in support of the STROBE statement for reporting of observational
studies [24].
3. Results
A general architecture of our proposed methodology is showing in Figure 1. A cohort
of 291 patients was eligible for the study. The mean age and BMI of the patients were
64 ± 10.5 yrs, respectively. The mean SCS was 3 ± 2 (2–11). Of these patients, 69/291
(23.7%) and 222/291 (76.3%) underwent PDS and IDS, respectively. Complete and optimal
cytoreduction was achieved in 190/291 (65.3%) and 78/291 (26.8%) patients. The details
of baseline characteristics and operative factors are displayed in Table 1 to enable the
better understanding of this group of patients undergoing cytoreductive surgery and
potentially requiring CCU admission. There were 56/291 (19.2%) admissions; of those,
49 admissions were elective whilst seven were unplanned admissions. From the variables
selected to predict CCU admission, the following variables were significantly different:
pre-treatment albumin, SCS, EBL, OT, and performance of bowel resection with stoma
formation (Figure 2). The correlation structure of pre-processed features was demonstrated
by a correlation heat map, as well as the most significant variables in Figure 3.
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Table 1. Pre-operative, intra-operative and post-operative parameters of the study cohort.
Variables (n = 291) Levels Frequency Percentage
Age, year, SD (range) N/A 64.2 ± 10.5 (41–90) N/A






mean, SD (min-max) N/A 38.3 ± 3.8 (17–49) U N/A
Surgical Complexity Score
(SCS)
Low (1–3) 166 57%
Moderate (4–7) 108 37.1%
High (8–12) 17 5.9%
Disease score (DS)
Pelvis 17 5.8%
Lower abdomen 220 75.6%
Upper abdomen 54 18.6%
Residual Disease (RD)
R0 190 65.3%
R1 (<1 cm) 78 26.8%















Low (0–2) 146 50.2%
High (≥3) 145 49.8%









Length of stay, mean, SD
(min-max) N/A 9 ± 13 (3–172) days N/A
Clavien-Dindo complications
(3a–5) Yes 16 5.5%
Admission within 30 days Yes Data Data
ECOG; Eastern Co-operative Oncology Group; PDS; primary debulking surgery, IDS; interval debulking surgery.
One sample from the training set was omitted due to missing values, totaling
290 patients with complete data, aiming to predict CCU admission. When all the vari-
ables were employed, the training accuracy from the derivation set ranged from 0.93 to
0.97. The corresponding internally validated (test) predictive accuracies for the KNN, ANN,
LDA, and QDA algorithms were 0.80, 0.82, 0.90 and 0.93, respectively. All but one F-score
were convincingly >0.80 (Table 2). Following feature reduction, we observed a slightly
worse, yet satisfactory performance with the mean accuracy across classifiers between 0.76
and 0.89 for the CCU admission prediction (Table 2). In that same table, the predictive
comparison between ML algorithms and LR suggested a significant outperformance for
LDA and KNN over LR. To guide model choice, a visual summary of all the operational
algorithms performed can be seen in Figure 3 for both the training and testing partitions.
Model performance remained robust between the training and test sets. When all the
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variables were included, the QDA model performed best in the training set (AUC: 0.98)
(Figure 3A). With feature selection, the smallest, highest-performing, and most robust
model was the LDA model in the training set (AUC: 0.97) (Figure 3C), yet it performed best
in the test set (AUC: 0.91) (Figure 3D).
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3.1. Mod l Deployment
To assess the clinical utility of our model, a user-friendly Graphical User Iinterface
of the CCU admission (the Leeds-Natal) risk score software macro was developed to
guide the observers through the analysis. The interface is av ilable upon request. In
brief, the interface provided probability results visualization of the risk position for
CCU admissio for clinical implementatio and easy interpretation by the phy icians
(Figure 4A). The model performance using the ANN(BPN) regression principle was akin to
the ML algorithms used (Figure 4B). We describe the implemen ation of our m thod in two
HGSOC patients, who underwent cytoreductive surgery (Figure 4C). Patient 1 underwent a
standard total abdominal hysterectomy, bilateral salpingo-ophorecto y, and omentectomy
following p mary chemoth rapy. This was a diffic lt procedure, completed in three hours
with an EBL of 1lt. Her probability of getting admi ted to CCU was only 1.49%, and she
was considered low risk. Patient 2 underwent a standard primary surgic l cytoreduction,
in addition to lymph node diss ction and pelvic peritoneal stripping. The EBL was 600 mL,
and the procedure was completed in 220 mi . Her risk for CCU admission was 32.56%
and she was still consid red low risk. If a rectosigmoid resection was anticipated intra-
operatively in that same patient, resulting in stoma formation, her SCS would increase
from 5 to 8, and her risk for CCU admission would rise to 84.27%.
3.2. Association between CCU Admission and Length of Stay, Post-Operative Complications, and
Hospital Re-Admission
Admission to CCU was associated with increased length of stay (p = 0.000; OR 8.0,
CI 7.7–8.35) and reduced risk for post-operative CD (3a-5) complications, (p = 0.001; OR 0.16,
CI 0.057–0.45) but no risk for re-admission within 30 days (p = 0.63).
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Table 2. Performance metrics of the Machine Learning models and comparisons with conventional
Logistic Regression for the prediction of Critical Care Unit admission following cytoreductive surgery
for advanced high grade serous ovarian cancer.






Train 0.94 0.78 0.97 0.86
CV LOO 0.94 0.78 0.97 0.86
Test 0.80 0.45 0.92 0.60
ANN
Train 0.97 0.96 0.97 0.96
CV LOO 0.88 0.85 0.88 0.86
Test 0.82 0.86 0.81 0.83
LDA Train 0.97 0.96 0.97 0.96Test 0.90 0.93 0.89 0.91
QDA Train 0.97 1.00 0.97 0.98Test 0.93 0.93 0.93 0.93






Train 0.94 0.89 0.95 0.92
CV LOO 0.94 0.89 0.95 0.92
Test 0.86 0.69 0.92 0.79
ANN
Train 0.90 0.89 0.90 0.99
CV LOO 0.89 0.89 0.89 0.89
Test 0.76 0.79 0.74 0.76
LDA Train 0.97 0.96 0.97 0.96Test 0.89 0.93 0.88 0.90
QDA Train 0.89 0.96 0.87 0.91Test 0.75 0.97 0.68 0.80
LR Train 0.95 0.78 0.98 0.87Test 0.82 0.55 0.92 0.69
* Surgical complexity score; pre-surgery albumin; blood loss; operative time; bowel resection with stoma. KNN;
k-Nearest Neighbors, ANN; Artificial Neural Network, CV-LOO; Leave-one-out-cross-validation; LDA; Linear
Discriminant Analysis, QDA; Quadratic Discriminant Analysis, LR; Logistic Regression.
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4. Discussion
In HGSOC, the recent paradigm shift towards achieving complete surgical cytoreduc-
tion has certain ramifications to prevent an anticipated increased peri-operative morbidity
and mortality [25]. For such a heterogenous disease, the accuracy of any related outcome
can be limited, prompting the development of new tools to improve prediction. In this
cohort study, we developed and fine-tuned several ML prediction algorithms that accu-
rately predicted CCU admission. Equally, we determined the importance of non-inherent,
hence potentially modifiable, prediction features. To our knowledge, this is the first study
to quantify patterns of CCU admission following cytoreductive surgery for HGSOC by
using ML methods.
Our study allowed for the comparison of several learning algorithms to identify the
approach with the most favorable performance. We demonstrated the utility of linear
discriminants (LDA, QDA) of clinical characteristics in model performance with maximum
accuracy reaching 98% and the lowest boundary of performance being no worse than 68%.
The overall model was rendered stable, owing to the quality of the fully curated training
data set. Although the study was not powered to the outcome prediction, the data sample
was large enough to capture any potential variance. Collinearity was successfully addressed
and reduced by feature selection, when required. In addition, we selected supervised ML
algorithms such as LDA, QDA, and KNN, which outperformed conventional LR with
respect to prediction accuracy indices, which is potentially more clinically relevant than
AUC. Such a comparison modeling system has already been shown to test intra-institutional
performances [24]. We are familiar with the performance of the KNN algorithm, which is
very much reflective of “previous clinical experience”, for the accurate prediction of R0
resection during HGSOC surgery [8]. Where the data classes were unbalanced, the tested
methods performed similarly to LR.
Confirming findings from prior empirical research, in addition to the premises of this
present work, our study identified those features with the maximal relevance to the CCU
admission prediction accuracy. All models placed importance on variables with known
predictive implications. All but one was intra-operative parameters. We acknowledge
that for planning purposes, it would have been more useful to predict CCU admission
based on more pre-operative variables; this was not possible due to the feature selection
process. Nevertheless, similar performance metrics were observed when all the variables
were included in the model. This highlights the value of the relative importance of each
predictor in developing the model. The significant variables may be differentially weighted
in the model analysis to reflect estimates of their contribution to relevant similarity. Some
discriminants have been previously shown to be predictors of short-term outcomes in EOC
patients [13]. Concurrent bowel resection with stoma formation, as part of a frequently
extensive cytoreductive surgery, was a critical predictor of CCU admission. This agrees
with findings from other studies [26]. It can be explained by the increased risk of severe
post-operative complications in patients who undergo rectosigmoid surgery during pelvic
exenteration [27]. Advanced stage HGSOC is commonly associated with weight loss, severe
malnutrition, and impaired gastrointestinal function, hence low pre-treatment albumin,
resulting in a protracted surgical recovery [28]. Primary chemotherapy could potentially
impact some of these factors, as shown to decrease intra-operative blood loss, earlier
resumption to ambulation, and return of intestinal function [29,30]. The effect of NACT on
post-operative admission to CCU remains controversial. Although primary chemotherapy
is associated with lower peri-operative morbidity and post-surgical mortality [31], this was
not correlated to CCU admission. New systemic treatment algorithms for newly diagnosed
advanced EOC could serve as tools to help with clinical decision making and patient
stratification on a daily basis [32].
Accurate identification of HGSOC patients at a quantified risk for CCU admission
following their surgery is important in gynaecologic oncology. Our findings demonstrated
that ML algorithms are able to predict a patient’s risk for CCU admission with excellent
discrimination. The main strength of the model was versatility, allowing for case mix when
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auditing the CCU admission as a proxy indicator of the quality of care. As specificity
was high for most models, this would make it attractive in a cancer screening program; if
diagnostic prediction is the goal, whereas both sensitivity (true positives) and specificity
(true negatives) are important, our highly performed linear discriminant algorithms (LDA
and QDA) would primarily apply. Nevertheless, such a tool could be useful in aiding a
clinician’s risk assessments in personalized management plans for patients. The develop-
ment of the first to our knowledge CCU risk calculator—the Leeds-Natal score—provided
a fine balance between high model accuracy and model simplicity that makes it easily
interpretable to the gynaecologic oncology surgeon. Based on five significant features, it can
evaluate which HGSOC subpopulation has the best prediction or which subpopulation is
most difficult to predict. In addition, it gives off certain advantages, such as the percentage
of those belonging to the “closest to admission” group, which is a ‘true idea’ of the real
probability of fitting in the group of women who should be admitted to CCU (Figure 4).
The rate of CCU admission was <20%. The length of CCU stays has been always
topical as extensive fluid resuscitation during surgery, poor nutritional status, and older age
are associated with a prolonged CCU stay [33]. A breakdown of planned and unplanned
admissions reflecting towards objective criteria with respect to valid peri-operative goal-
directed haemodynamic therapy protocols is an important topic, and research is currently
under way. Herein, although the CCU admission rate increased transiently from 2014 to
2019, the rate of unplanned admissions remained steady (data not shown). In HGSOC,
unplanned admissions are associated with reportedly poor survival outcomes [34]. In
high-output tertiary centres, interdisciplinary meetings to allocate and prioritize CCU beds
prior to the surgical cases may have translated into the observed increased planned and
decreased unplanned post-operative CCU admissions.
Prolonged hospitalizations, CCU stays, and hospital re-admissions, have all come
under scrutiny due to increasing emphasis on improving palliative care and quality of life
for patients near their end of life [35]. Admission to CCU contributes to increased costs for
both patients and hospitals [36]. In our post-hoc analysis, CCU admission has been inde-
pendently associated with increased hospitalization, fewer post-operative complications,
but no effect on the risk of re-admission within 30 days, in contrast to other studies [34].
If extensive surgery is associated with morbidity-related infections and wound complica-
tions, it may be prudent to provide nutrition support ensuring the peri-operative period
in these women [37]. In that same report, CCU admission increased the odds of severe
surgical infections, compared to routine ward admission. For such an inherently high-risk
population, this information is critical when counseling women about peri-operative risks
ahead of their surgery, and potential adverse impacts in their overall survival.
This was a single-centre study with a limited rate of heterogeneity in the study popu-
lation, which may differ from other tertiary unit settings. The retrospective nature of the
study was the main limitation, despite a proprietary, prospectively maintained database. A
very slight discordance of model performance between the training and test sets may not
be generalized to other data sources. Nevertheless, ML retains the strength of the structural
model used for the prediction, even when applied to other populations with different pre-
diction features. Although model robustness was strongly supported by internal validation,
further external validation in an independent cohort may be required to confirm the ability
of the models as guidance tools.
5. Conclusions
In high-output centres, CCU admission is a measurable outcome that can be used as
a benchmark of surgical care. We developed ML models that predicted CCU admission
following cytoreductive surgery for HGSOC with an accuracy as high as 98%. Equally,
we refined risk-adjusted predictors of CCU admission using pertinent pre-operative and
intra-operative variables. Most importantly, we demonstrated clinical feasibility by the
development of a Graphical User-friendly Interface to quantify patterns of CCU admission.
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Predictive ML algorithms may facilitate quality improvement of modern care by improving
the CCU admission prediction accuracy.
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